Unesp Iron Nanoparticle Eradicates TB in Mice | AcademicJobs
Unesp researchers develop iron-based nanoparticle that fully eliminates tuberculosis in mice lungs after 30 days, promising shorter, safer treatments amid Brazil's rising TB cases.
No reviews yet. Be the first to rate Fernando!
Fernando Rogério Pavan is an Associate Professor and Tenured Professor in Microbiology at the Department of Biological Sciences, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista (UNESP), Campus de Araraquara. He earned his degree in Biomedical Sciences from FCF/UNESP in 2004, followed by a master’s degree in 2008 and a doctoral degree in 2011 from the same institution. During his doctoral studies, he completed a research internship at the Institute for Tuberculosis Research at the University of Illinois at Chicago in 2010. He subsequently undertook a postdoctoral fellowship at FCF/UNESP from 2011 to 2012.
Pavan serves as a CNPq Researcher Level 1C and leads the CNPq research group on New Drug Discovery for Tuberculosis. He coordinates the Tuberculosis Drug Research Division within the REDE-TB network and directs regular and thematic projects funded by FAPESP focused on TB drug discovery. He has supervised master’s, doctoral, and postdoctoral researchers as a permanent member of the Graduate Program in Biosciences and Biotechnology Applied to Pharmacy (CAPES Level 7) since 2012. Pavan previously served as Head of the Department of Biological Sciences at FCF/UNESP for two terms from 2020 to 2024 and as Chair of the Permanent Research Committee from 2016 to 2017. He has received the CAPES Interfarma Thesis Award in 2018 and the UNESP Best Thesis Award in 2018 as an advisor. Pavan maintains editorial board roles with journals including the Brazilian Journal of Microbiology and Frontiers in Drug Discovery, acts as a reviewer for publications such as Nature and The Lancet Infectious Diseases, and has established international collaborations with institutions including King’s College London, the Francis Crick Institute, the University of Copenhagen, CIC biomaGUNE, the University of Lisbon, the University of Siena, the National Institutes of Health, and the University of Illinois at Chicago.
Unesp researchers develop iron-based nanoparticle that fully eliminates tuberculosis in mice lungs after 30 days, promising shorter, safer treatments amid Brazil's rising TB cases.